2001
DOI: 10.1128/jcm.39.2.740-742.2001
|View full text |Cite
|
Sign up to set email alerts
|

Maxillary Sinusitis Caused by Actinomucor elegans

Abstract: We report the first case of maxillary sinusitis caused by Actinomucor elegans in an 11-year-old patient. Histopathological and mycological examinations of surgical maxillary sinuses samples showed coenocytic hyphae characteristic of mucoraceous fungi. The fungi recovered had stolons and rhizoids, nonapophyseal and globose sporangia, and whorled branched sporangiophores and was identified as A. elegans. After surgical cleaning and chemotherapy with amphotericin B administered intravenously and by irrigation, th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
14
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 5 publications
0
14
0
Order By: Relevance
“…The first was described in 2001 for an immunocompetent 11-year-old girl diagnosed with maxillary sinusitis from which Actinomucor elegans was isolated (80). This patient underwent surgical cleaning and treatment with AmB.…”
Section: Actinomucor Elegansmentioning
confidence: 99%
“…The first was described in 2001 for an immunocompetent 11-year-old girl diagnosed with maxillary sinusitis from which Actinomucor elegans was isolated (80). This patient underwent surgical cleaning and treatment with AmB.…”
Section: Actinomucor Elegansmentioning
confidence: 99%
“…Most common predisposing factor reported has been diabetes [9]. Cases of mucormycosis without any predisposing factors have also been reported in the literature [10,11].…”
Section: Discussionmentioning
confidence: 99%
“…These are opportunistic infections, reported to occur in association with Diabetes mellitus [1,2,6], leukemias and lymphomas [3], chronic renal failure, and HIV. It is seen to have varied clinical presentations, ranging from limited nose and paranasal [4] to rhino-orbital [5], rhino-cerebral [6], cutaneous, pulmonary, disseminated [7] or intestinal involvement. With the improved diagnostic tools and effective treatment strategies the prognosis has improved in this otherwise fatal infection [8].…”
Section: Introductionmentioning
confidence: 99%
“…The susceptibility pattern of A. elegans was only determined previously in two cases. In the paper by Davel et al (2), the MICs were as follows: amphotericin B, 2 g/ml; and itraconazole, 1 g/ml. In the paper by Khan et al (4), the MICs were as follows: amphotericin B, 1 g/ml; voriconazole, 8 g/ml; posaconazole, 0.25 g/ml; and caspofungin, Ͼ32 g/ml.…”
Section: Case Reportmentioning
confidence: 99%